MAPT and Alzheimer disease: This MAPT KI mouse model differs from the MAPT mutation mouse models in that instead of artificially introducing mutant tau, it allows studying development of AD pathology and the impact of environmental factors on these pathology through recapitulation of human wildtype tau conditions.